NOVEMBER 18, 2026
Subscribe
Global Press Media · World Report
Technology

NHS to keep Palantir data deal until 2029 despite Labour objections

NHS to keep Palantir data deal until 2029 despite Labour objections

Government officials said on Thursday that the UK's National Health Service will maintain its data‑analytics collaboration with US software company Palantir Technologies through 2029, turning down demands from a number of Labour MPs to end the deal sooner.

Under the current contract, Palantir supplies the NHS with a system that consolidates patient records from hospitals, clinics and other providers, enabling analysts to monitor service pressures, predict demand and aid clinical decision‑making. The agreement, first signed in 2022, is scheduled to run for another six years, with a fresh procurement process only to begin after the present term finishes.

Labour voices have expressed alarm over a foreign, for‑profit firm handling sensitive health data, contending that the arrangement lacks sufficient transparency and may not represent value for money. During a recent parliamentary debate, a small group of MPs urged the health secretary to launch a new tender and explore alternatives based in the UK tech sector.

Ministers counter that the choice to preserve the status quo is driven by practical reasons. They point out that the Palantir platform is now woven into NHS operations, powering pandemic‑response dashboards and capacity‑planning tools that proved vital during recent winter pressures. Officials also note that ending the contract early could disrupt services and trigger substantial financial penalties.

The Department of Health and Social Care said a formal review of the contract’s performance will be carried out, but any new bidding process will not start until the existing agreement lapses in 2029. This schedule follows standard public‑sector procurement rules, which generally require a full contract cycle before a new competition is opened.

Industry watchers observe that the extended partnership underscores wider UK tensions between exploiting advanced data analytics and protecting public data sovereignty. While Palantir’s technology is lauded for its scalability, critics warn that reliance on an overseas supplier may hinder the growth of domestic capabilities.

Looking forward, the NHS is set to keep using the Palantir platform while also probing additional tools and open‑source solutions that could complement its current analytics. The government has pledged to release a detailed assessment of the contract’s outcomes once the present term ends, offering clearer insight into whether future tenders will attract new participants.

For the time being, the health service’s data infrastructure will stay under Palantir’s control, with both supporters and opponents watching closely as the next stage of digital transformation unfolds within the NHS.

Editorial Desk — Editorial desk.

Comments (0)

Be the first to comment.

Join the discussion

Protected by reCAPTCHA v3

Related